LC
Lee Cooper
Managing Director at Delos Capital
LC
Lee Cooper
Managing Director at Delos Capital
Greater Boston
Overview
Work Experience
Managing Director
2024 - Current
Faculty Lecturer
2021
ENGS 15.03 - Ecosystem for Bio-Innovation
Lecturer
2022
Bio 196 - Exploratory Topics in Biology
Director, Venture Investments
2020 - 2024
Investments and/or board service include: Capstan Therapeutics, Recursion ($RXRX), Gandeeva Therapeutics, Senti Bio ($SNTI), Ukko, Pyxis ($PYXS), Cellino, Triumvira, Ukko, Century Tx ($IPSC), Ada Health, others
Entrepreneur In Residence
2018 - 2019
Biotech venture formation and investment diligence.
Founder
2018 - 2019
Patient-centered genomics company formed with support from RA Capital.
Associate Director, Business Development
2015 - 2017
Partnerships and financing to advance vaccines and therapeutics in infectious disease, oncology, and rare genetic disease.
Technology and Life Sciences Practice
2014 - 2014
Strategy Consultant
2009 - 2012
Director of International Programs
2009 - 2009
Education
Latest Articles
Medium•Jan. 2022
High-Resolution Images to Navigate Drug Discovery
Medium•Dec. 2018
To Fight High-Priced Drugs, Sidestep the Disease
Talks about Health, Genetics and Reproductive Health
Medium•Feb. 2018